Home > Newsletters > International Pharmaceutical Regulatory Monitor > Industry Calls for More Resources to Expedite Generic Drug Approvals in Europe
International Pharmaceutical Regulatory Monitor
March 2007 | Vol. 35 No. 3
Industry Calls for More Resources to Expedite Generic Drug Approvals in Europe
Generic drug firms operating in the European Union (EU) should work closely with state agencies to mitigate drug approval delays caused by bureaucratic overload, the European Generic medicines Association (EGA) said at an industry conference in February.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.